Tomorrow after the bell, Micron Technology (MU) drops its fiscal Q3 2026 results. Consensus is sitting at roughly $34.7 billion in revenue and EPS near $19.95. Those are numbers that, eighteen months ago, would have seemed like satire for a memory chip company. And yet, here we are.
The thing is, the headline figures almost don’t matter anymore.
What actually matters is what Micron’s CEO says about HBM allocation into 2027, whether the supply gap is narrowing, and how aggressively they guide Q4. That’s the tape traders are reading. Not whether they beat by fifty cents.
Analyst Targets
- Deutsche Bank (Melissa Weathers): Buy, $1,000 PT
- DA Davidson (Gil Luria): Buy, $1,000 PT
- TD Cowen (Krish Sankar): Buy, $660 PT
- Mizuho (Vijay Rakesh): Buy, $740 PT
- RBC Capital: Buy, raised to $1,200 PT
- Cantor Fitzgerald (C.J. Muse): $1,500 PT (Street high)
What the Quarter Should Show
Micron guided for record Q3 revenue of roughly $33.5 billion, gross margins near 81%, and non-GAAP EPS of $19.15 — guidance that already exceeded any prior full-year revenue figure in the company’s history. The Street consensus has crept above that. Fiscal 2026 full-year EPS is now projected around $57.71, up 651% from $7.68 in fiscal 2025.
The margin math is the part that quietly reframes the entire valuation argument. Micron’s own Q3 guidance implies that nearly 97 cents of every additional revenue dollar flows straight into gross profit. That’s not a software company. That’s a chip manufacturer running out of product to sell.
Why the Stock Is Here
Micron crossed $1 trillion in market cap in late May after UBS analyst Timothy Arcuri nearly tripled his price target to $1,625, arguing the HBM supply-demand imbalance was structurally durable. That wasn’t analyst hyperbole for once. Micron has said its projected calendar 2026 HBM supply is fully allocated. CEO Sanjay Mehrotra has said publicly the company can fulfill only 50% to two-thirds of key customer demand in the near term. New fabrication and packaging capacity is expected to contribute more meaningfully in calendar 2027 and beyond.
Goldman Sachs pegged the 2026 DRAM supply-demand gap at 4.9%, calling it the most severe shortage in 15+ years. That’s not a temporary blip. It’s a pricing environment Micron hasn’t seen in a generation.
Slight tangent here, but worth noting: Micron is the only American company in the three-player HBM oligopoly. SK Hynix leads HBM, Samsung is the largest DRAM maker overall, and Micron is targeting 20-25% HBM share by late 2026. The geopolitical angle, especially post-CHIPS Act, gives Micron a domestic manufacturing story most semiconductor names can’t claim. That matters for long-duration institutional positioning more than near-term earnings beats.
The Numbers in Context
- Q2 FY2026 Revenue: $23.9B (+196% YoY) — largest sequential dollar increase in company history
- Q2 DRAM revenue: $18.8B (+207% YoY); NAND: $5.0B (+169% YoY)
- Q3 guidance: Revenue ~$33.5B, gross margin ~81%, EPS $19.15
- FY2026 CapEx guidance: Above $25B; FY2027 construction-related CapEx stepping up by more than $10B YoY
- HBM TAM projection: $100B by 2028, approximately 40% CAGR
Bull / Base / Bear
Bull: HBM4 allocations expand beyond Nvidia into AMD and custom silicon customers. Gross margin sustains above 80% through FY2027. Stock closes the gap toward the $1,200 range as full-year EPS trajectory justifies a re-rating toward Nvidia-like multiples. The structural supply deficit thesis holds, and no new meaningful HBM supply enters before late 2027.
Base: Micron beats Q3 estimates, guides Q4 in-line to modestly above, and the stock grinds higher with broader semiconductor sentiment. Margins stay rich, HBM contracts hold, but hyperscaler spending shows early signs of digestion. Stock stays range-bound in the $900 to $1,100 zone as investors wait for FY2027 clarity.
Bear: A hyperscaler pulls back AI capex commitments, or Samsung resolves its HBM yield issues faster than expected, adding a third meaningful supplier to the market. Memory pricing begins moderating earlier than guided. The stock, which already trades at a significant premium to historical memory multiples, reprices sharply lower if the cycle-change thesis cracks even slightly.
Technical Read
MU has been consolidating between roughly $900 and $1,050 for several weeks heading into earnings. Options traders are pricing in a 14% post-earnings swing in either direction. Key resistance sits at the prior all-time high above $1,100. Support below is the 50-day moving average near $850. A strong Q4 guide could push the stock through resistance and into price discovery. A miss or cautious HBM commentary could send it back toward the $750 range fast.
What to Watch Tomorrow
- HBM4 shipment ramp timeline — how much volume lands in fiscal Q4 versus pushed into FY2027
- Any Nvidia Vera Rubin platform allocation commentary
- NAND guidance and whether pricing is holding against supply pressure
- Forward capex language — the $25B FY2026 figure is already elevated, and guidance for FY2027 will shape how investors think about free cash flow
- Whether robotics demand gets formally embedded in multi-year supply agreements
Bottom Line
The debate around Micron has shifted from cyclical recovery to something harder to dismiss: whether AI has permanently broken the boom-bust memory pattern. DA Davidson’s Gil Luria put it plainly — the market is still treating this cycle like a normal downturn replay and likely underestimating demand durability. If Micron’s Q4 guide confirms that, the $1,000-plus price targets start looking less like ambition and more like math. What moves the stock tomorrow isn’t the revenue line. It’s every word Mehrotra says about 2027 supply.
For informational purposes only.
